Browse back issues of The Atlantic from 1857 to present
that have appeared on the Web.
From September 1995 to the present, the archive is essentially complete,
with the exception of a few articles,
the online rights to which are held exclusively by the authors.
The Tech Issue: The Pentagon aims to weaponize the brain, a generation of kids raised on YouTube, and Alexa’s most dangerous feature. Plus how Newt Gingrich broke politics, Pope Francis and Óscar Romero, the case for liberal Republicanism, Knausgaard devours himself, the personal cost of black success, and more.
The crisis in democracy: articles by Anne Applebaum, Stephen Breyer, Jeff Rosen, David Frum, Amy Chua, and others. Plus the price of sports protests, what getting shot taught Elaina Plott about American politics, the brutal truth about climate change, why #brands are not our friends, James Parker on Rick and Morty, and more.
How courtrooms are inhospitable to female trial lawyers, the nasty scientific feud over what killed the dinosaurs, and how your brain deceives you. Plus the rise of Latino populism, Caitlin Flanagan on ‘Lolita,’ American poetry’s next generation, what your work emails reveal, YouTube’s gun guru, and more.
The Health Report: America isn’t prepared for the next plague, the life-expectancy gap between black and white Americans, and when children say they’re trans. Plus William Langewiesche on a B-2 stealth raid in Libya, the formula for team chemistry, the dangers of distracted parenting, Jean-Michel Basquiat, weird DNA, and more.
A Muslim among Israeli settlers, the pearl at the center of an 80-year-old hoax, Marti Noxon putting women’s rage on TV, and pop culture’s response to Trump. Plus, Kissinger on AI and the end of humanity, an interview with Seth Meyers, the search for life on Mars, NRATV, and more.
The Sports Report: Malcolm Jenkins, praise for fair-weather fans, Floyd Landis takes down Lance Armstrong, and the mobster who bought his kid a hockey team. Plus the U.S. military’s plunging morale, James Fallows on reinventing America, a new era of fake videos, an interview with Issa Rae, and more.
The women who busted a con man, refugee detectives in Germany, and why cartoonists struggle with drawing Trump. Plus the problem with Nancy Pelosi’s effectiveness, BLM meets sci-fi, an interview with Cory Booker, fiction by Mary Morris, and much more.
Why the Chinese love Trump, Paul Manafort and the corruption of U.S. politics, how we will feed the new global middle class, and why you should boycott the GOP. Plus, Mark Bowden revisits the world’s most body-conscious man, Caitlin Flanagan on Modesty Blaise, the failure of American democracy, fiction by Will Mackin, and more.
Russia’s election-hack gamble, God’s plan for Mike Pence, and the case against college for everyone. Plus, exoneration without DNA evidence, Eva Moskowitz’s charter-school revolution, the jellyfish apocalypse, and more.
The crucial hours after a fraternity pledge’s fall, what Thoreau really saw, and the secrets of Google’s moonshot factory. Plus, the enduring appeal of Joni Mitchell, the science behind Mona Lisa’s smile, and more.
A damage report on the presidency by Ta-Nehisi Coates, Eliot Cohen, and Jack Goldsmith. Plus, Woody Allen’s lazy filmmaking, Joyce Maynard’s personal-essay domination, and why happy people cheat on their spouses.
A family’s secret slave in America, Richard Spencer’s transformation, skydiving from space, and a new approach to helping psychopathic children. Plus, Pixar’s decline, Trump’s potential impact on the economy, and more.
The Money Report: how online shopping makes suckers of us all, how Walmart tricks people into saving, the plan to end Europe, and late-night comedy’s role in the rise of Trump. Plus, apps for aid in a humanitarian crisis, and more.
Kellyanne Conway as the Trump whisperer, Pleistocene Park, why Silicon Valley is so awful to women, and what your therapist doesn’t know. Plus, what secularization has done to American politics, and more.
President Trump’s autocratic potential, a social-media mom’s empire, blue cities in red states, and luxury doomsday bunkers. Plus, what sexuality looked like in the Victorian era, how to fix Hollywood, and more.
The Tech Issue: The view from Silicon Valley, how social media is changing war, and breaking your internet addiction. Plus, a rare presidential endorsement, Jane Jacobs on the fragility of democracy, and much more
The Politics Issue: A presidential Ponzi scheme, sizing up the debates, Trump’s punk-rock appeal, and female-leader backlash. Plus, museums learn to love selfies, the failure of poetry, Ta-Nehisi Coates on O. J. Simpson, and much more.
Transplanting human heads to save lives, evaluating U.S. homeland security 15 years after 9/11, how the plight of the white underclass drives American politics, reclaiming critical inquiry in Vietnamese schools, and much more
The mystery behind Jesus’s (probably fake) wife, white nationalism in the GOP, the timepieces of the rich and famous (and powerful), a potential diagnosis on American politics, Liberia after Ebola, and much more
For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.
The world is now engaged in a vaccination program unlike anything we have seen in our lifetimes, and with it, unprecedented scrutiny of ultra-rare but dangerous side effects. An estimated 852 million COVID-19 vaccine doses have been administered across 154 countries, according to data collected by Bloomberg. Last week, the European Medicines Agency, which regulates medicines in the European Union, concluded that the unusual clotting events were indeed a side effect of the AstraZeneca vaccine; by that point, more than 220 cases of dangerous blood abnormalities had been identified. Only half a dozen cases have been documented so far among Americans vaccinated with the Johnson & Johnson vaccine, and a causal link has not yet been established. But the latest news suggests that the scope of this problem might be changing.
Beth Van Duyne was at the center of a controversy over Sharia law. Now she represents a congressional district Biden won.
In 2015, in the Dallas suburb of Irving, the fates of two very different Texans collided.
One was 14-year-old Ahmed Mohamed, a precocious kid in a NASA T-shirt who had built a clock out of spare parts and brought it to school in a pencil case. His English teacher decided it might be a bomb, and the school called the police, who arrested Mohamed for bringing in a “hoax bomb.” Because Mohamed’s family was part of Irving’s large Muslim minority, many liberals saw this as a baseless case of Islamophobia.
The other Texan was Irving Mayor Beth Van Duyne, a blond 44-year-old with Disney-princess bone structure. She defended Mohamed’s arrest on Facebook, then went on The Glenn Beck Program to repeat the “hoax bomb” lie and complain that the child hadn’t given police enough information. “We’ve heard more from the media than the child ever released to the police when we were asking him questions,” she said calmly.
Concerns about blood clots with Johnson & Johnson underscore just how lucky Americans are to have the Pfizer and Moderna shots.
A year ago, when the United States decided to go big on vaccines, it bet on nearly every horse, investing in a spectrum of technologies. The safest bets, in a way, repurposed the technology behind existing vaccines, such as protein-based ones for tetanus or hepatitis B. The medium bets were on vaccines made by Johnson & Johnson and AstraZeneca, which use adenovirus vectors, a technology that had been tested before but not deployed on a large scale. The long shots were based on the use of mRNA, the newest and most unproven technology.
The protein-based vaccines have moved too slowly to matter so far. J&J’s and AstraZeneca’s vaccines are effective at preventing COVID-19—but a small number of recipients have developed a rare type of blood clot that appears to be linked to the adenovirus technology and may ultimately limit those shots’ use. Meanwhile, with more than 180 million doses administered in the U.S, the mRNA vaccines have proved astonishingly effective and extremely safe. The unusual blood clots have not appeared with Pfizer’s or Moderna’s mRNA technology. A year later, the risky bet definitely looks like a good one.
Just months after leaving office, the former president has all but disappeared.
The president was insistent as he left office: “We’re not going anywhere.” It had been a turbulent end of the presidency—impeachment, appalling pardons, and a lengthy dispute over the outcome of the presidential election—but he knew that he had a devoted following, and he had every intention to remain a force in politics. And not just him: His family was eager to cash in on his electoral success, too. Usually a former president laid low for a while after leaving office. He wasn’t going to do that. He’d remain a political force, and the dominant figure in his party.
But the plan didn’t go well. The president sat at his new home—he had decamped from his longtime home state—guzzling Diet Cokes and calling friends to rage about how unfairly he’d been treated and complain about overzealous prosecutors. “You get tired of listening to it,” one friend confessed.
In 1974, John Patterson was abducted by the People’s Liberation Army of Mexico—a group no one had heard of before. The kidnappers wanted $500,000, and insisted that Patterson’s wife deliver the ransom.
Illustrations by Leonardo Santamaria
This article was published online on April 15, 2021.
The Motel El Encanto in Hermosillo, Mexico, served a lavish breakfast that John and Andra Patterson liked to eat on the tiled deck near their suite. The couple would discuss the day ahead over fresh pineapple and pan dulces while their 4-year-old daughter, Julia, watched the gray cat that skulked about the motel’s Spanish arches.
On the morning of March 22, 1974, the Pattersons’ breakfast chatter centered on their search for a permanent home. They were nearing their two-month anniversary of living in Hermosillo, where John was a junior diplomat at the American consulate, and the motel was feeling cramped.
After breakfast, Andra dropped John off at work. Because this was his first posting as a member of the United States Foreign Service, the 31-year-old Patterson had been given an unglamorous job: He was a vice consul responsible for promoting trade between the U.S. and Mexico, which on this particular Friday meant driving out to meet with a group of ranchers who hoped to improve their yield of beef.
The CDC has finally said what scientists have been screaming for months: The coronavirus is overwhelmingly spread through the air, not via surfaces.
Last week, the CDC acknowledged what many of us have been saying for almost nine months about cleaning surfaces to prevent transmission by touch of the coronavirus: It’s pure hygiene theater.
“Based on available epidemiological data and studies of environmental transmission factors,” the CDC concluded, “surface transmission is not the main route by which SARS-CoV-2 spreads, and the risk is considered to be low.” In other words: You can put away the bleach, cancel your recurring Amazon subscription for disinfectant wipes, and stop punishing every square inch of classroom floor, restaurant table, and train seat with high-tech antimicrobial blasts. COVID-19 is airborne: It spreads through tiny aerosolized droplets that linger in the air in unventilated spaces. Touching stuff just doesn’t carry much risk, and more people should say so, very loudly.
More Black storytellers are turning to the horror genre to unpack the traumas of racism. But some viewers are growing tired of these stories.
In the trailer for Amazon’s new horror series, Them, Diana Ross’s “Home” soundtracks a tender scene: A Black husband and wife in the 1950s survey their new house in wonder and dance in the living room with their two daughters. “When I think of home / I think of a place where there’s love overflowing,” Ross sings. But, as in the song, the tenor of the trailer changes. We learn that the Emory family has moved to a white part of Compton, where residents don’t take kindly to the demographic shift. “They came from someplace worse. We’ll have to make this place worse,” one neighbor says. A montage of racist harassment follows: White classmates make ape noises at one Emory daughter; golliwog dolls hang from the family’s roof; a church is set ablaze.
Progressives thought they knew what a Biden presidency would look like. How did they get him so wrong?
Washington in the first days of the Biden administration is a place for double takes: A president associated with the politics of austerity is spending money with focused gusto, a crisis isn’t going to waste, and Senator Bernie Sanders is happy.
People like to tell you they saw things coming. But as I talked to many of the campers in Joe Biden’s big tent, particularly those who, like me, were skeptical of Biden, I found that the overwhelming sentiment was surprise. Few of us expected that this president—given his record, a knife’s-edge Congress, and a crisis that makes it hard to look an inch beyond one’s nose—would begin to be talked about as, potentially, transformational.
Biden, after all, was a conservative Democrat who has exuded personal decency more than he has pushed for structural decency. One conservative publication labeled him “the senator from MBNA” for his friendliness to credit-card companies. He conducted the Clarence Thomas–Anita Hill hearings in a way that hurt Hill, for which he later expressed regret. He voted for the Iraq War and eulogized the segregationist Senator Strom Thurmond. He began his 2020 campaign telling wealthy donors that, in his vision, “nobody has to be punished. No one’s standard of living will change, nothing would fundamentally change.”
The joys of money are nothing without other people.
“How to Build a Life” is a weekly column by Arthur Brooks, tackling questions of meaning and happiness.
Arthur C. Brooks will discuss the science of happiness live at 11 a.m. ET on May 20. Register for In Pursuit of Happiness here.
In 2010, two Nobel laureates in economics published a paper that created a tidal wave of interest both inside and outside academia. With careful data analysis, the researchers showed that people believe the quality of their lives will increase as they earn more, and their feelings do improve with additional money at low income levels. But the well-being they experience flattens out at around $75,000 in annual income (about $92,000 in today’s dollars). The news materially affected people’s lives—especially the part about happiness rising up to about $75,000: In the most high-profile example, the CEO of a Seattle-based credit-card-payment company raised his employees’ minimum salary to $70,000 (and lowered his own salary to that level) after reading the paper.
People who refuse to get the COVID-19 vaccine will have higher health-care costs. The rest of us will foot the bill.
Imagine it’s 2026. A man shows up in an emergency room, wheezing. He’s got pneumonia, and it’s hitting him hard. He tells one of the doctors that he had COVID-19 a few years earlier, in late 2021. He had refused to get vaccinated, and ended up contracting the coronavirus months after most people got their shots. Why did he refuse? Something about politics, or pushing back on government control, or a post he saw on Facebook. He doesn’t really remember. His lungs do, though: By the end of the day, he’s on a ventilator.
You’ll pay for that man’s decisions. So will I. We all will—in insurance premiums, if he has a plan with your provider, or in tax dollars, if the emergency room he goes to is in a public hospital. The vaccine refusers could cost us billions. Maybe more, over the next few decades, with all the complications they could develop. And we can’t do anything about it except hope that more people get their shots than those who say they will right now.